Published in J Clin Microbiol on February 09, 2011
Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012. Eur J Clin Microbiol Infect Dis (2014) 0.91
Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. J Clin Microbiol (2012) 0.86
Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013. Eur J Clin Microbiol Infect Dis (2014) 0.78
Genetic Profile Variation in Vaccine Strains and Clinical Isolates of Bordetella pertussis Recovered from Iranian Patients. Avicenna J Med Biotechnol (2014) 0.76
Virulence Factors Variation Among Bordetella Pertussis Isolates in Iran. Int J Mol Cell Med (2015) 0.75
Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun (1998) 3.76
Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis (2000) 3.09
Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol (2004) 2.58
Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis (2001) 2.41
Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J Infect Dis (1999) 2.25
Resurgence of pertussis in Europe. Pediatr Infect Dis J (2005) 2.23
Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun (1999) 2.09
Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis (2000) 2.05
Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol (2001) 2.02
Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol (2009) 1.79
Genetic relatedness of Bordetella species as determined by macrorestriction digests resolved by pulsed-field gel electrophoresis. Int J Syst Bacteriol (1993) 1.76
Pertussis in Poland. Int J Epidemiol (2004) 1.64
Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun (2001) 1.64
Is Bordetella pertussis clonal? BMJ (1992) 1.59
Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol (2009) 1.48
Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine (2001) 1.42
Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol (2005) 1.41
Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J (2003) 1.39
Bordetella pertussis strain variation and evolution postvaccination. Expert Rev Vaccines (2009) 1.38
Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect (2005) 1.36
Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J Clin Microbiol (2004) 1.35
Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol (2004) 1.34
Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol (2005) 1.28
Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics (2008) 1.26
Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol (2005) 1.23
Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine (2006) 1.06
Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin Vaccine Immunol (2007) 1.05
Bordetella pertussis, Finland and France. Emerg Infect Dis (2006) 1.05
Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol (2007) 1.04
Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods (2009) 1.03
Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol (2008) 1.02
Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan. Vaccine (2008) 1.01
Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype. APMIS (2007) 0.98
Effect of vaccination on Bordetella pertussis strains, China. Emerg Infect Dis (2010) 0.98
Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas. Microbes Infect (2008) 0.90
Molecular epidemiology of Bordetella pertussis isolated in Taiwan, 1992-1997. Microbiol Immunol (2003) 0.88
Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004. APMIS (2007) 0.88
Potency of pertussis component in the DTP vaccine--an overview of three decade study in Poland. Biologicals (2004) 0.88
The outbreak that had to happen: Bordetella pertussis in north-west Western Australia in 1999. Commun Dis Intell (2000) 0.87
Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009. Res Microbiol (2010) 0.87
Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine. Vaccine (2005) 0.82
[Immunity of children aged 6-8 against pertussis, tetanus and diphtheria]. Przegl Epidemiol (2002) 0.79
Bordetella pertussis vaccine strains and circulating isolates in Serbia. Vaccine (2009) 0.78
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76
Pertussis in Poland. Int J Epidemiol (2004) 1.64
Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infect Genet Evol (2011) 1.01
Potency of pertussis component in the DTP vaccine--an overview of three decade study in Poland. Biologicals (2004) 0.88
Bone-composition imaging using coherent-scatter computed tomography: assessing bone health beyond bone mineral density. Med Phys (2006) 0.87
[Amplification reaction to bacterial DNA for diagnosing infective endocarditis]. Med Dosw Mikrobiol (2002) 0.80
Amplified fragment length polymorphism (AFLP) versus randomly amplified polymorphic DNA (RAPD) as new tools for inter- and intra-species differentiation within Bordetella. J Med Microbiol (2005) 0.80
Development of broad-range polymerase chain reaction (PCR) bacterial identification in diagnosis of infective endocarditis. J Heart Valve Dis (2002) 0.80
The capacity of Mycobacterium tuberculosis complex species and M. bovis BCG substrains specific identification - implications for optimized PCR-based diagnostics in adverse events following vaccination suspected cases. Pol J Microbiol (2012) 0.75
[Sources of information and knowledge on childhood immunisations among Polish parents]. Przegl Epidemiol (2010) 0.75
Multiplex-PCR as an identity assay for Mycobacterium bovis BCG Moreau descendants. Biologicals (2013) 0.75
The possible effect of a sanitization program on intraspecies differentiation of Listeria monocytogenes strains isolated from a fish processing plant. Int J Hyg Environ Health (2003) 0.75
[Detection of the adventitious agents in the evaluation of vaccine safety]. Przegl Epidemiol (2012) 0.75
[Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults]. Przegl Epidemiol (2012) 0.75
[Transmission of Haemophilus influenzae type b strains among children attending day-care centers and orphanages]. Med Dosw Mikrobiol (2005) 0.75
Effectiveness of experimental whole-cell pertussis vaccines in murine model. Med Dosw Mikrobiol (2014) 0.75
[Evaluation of Bordetella pertussis strains toxicity in vitro using CHO cell lines]. Med Dosw Mikrobiol (2014) 0.75
[Increase in the incidence of pertussis and quality of whole-cell pertussis component of the DTP vaccine produced in Poland. Part I. Potency of DTP vaccine]. Przegl Epidemiol (2004) 0.75
[Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations]. Med Dosw Mikrobiol (2007) 0.75
Application of the MALDI-TOF for identification of Clostridium perfringens strains. Med Dosw Mikrobiol (2017) 0.75
[Phenotypic and genotypic characterization of probiotic bacterial strains used in medicinal products]. Med Dosw Mikrobiol (2013) 0.75
[Genetic variability of Bordetella pertussis strains. Part I. Current knowledge]. Przegl Epidemiol (2003) 0.75
[Polymorphism analysis of Haemophilus influenzae strains isolated from healthy children with respect to amplification reaction]. Med Dosw Mikrobiol (2003) 0.75
[The studies of elimination of nontypeable Haemophilus influenzae strains using the animal model of infection]. Med Dosw Mikrobiol (2013) 0.75
Erratum: Global phylogeography and evolutionary history of Shigella dysenteriae type 1. Nat Microbiol (2016) 0.75
[Genetic variability of Bordetella pertussis strains. Part II. Perspectives]. Przegl Epidemiol (2003) 0.75
[Evaluation of whole-cell and acellular pertussis vaccines effectiveness in clearance of experimental B. pertussis infection in mice]. Med Dosw Mikrobiol (2007) 0.75
[Immunization of adolescents and adults as the strategy of improvement of epidemiology of pertussis]. Przegl Epidemiol (2011) 0.75
Descendant of daughter Brazilian BCG Moreau substrain in Poland. Vaccine (2012) 0.75
Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model. Vaccine (2011) 0.75
[Broad-range fungal PCR in diagnosis of complicated infective endocarditis]. Pol Arch Med Wewn (2002) 0.75
Colonization of Bordetella pertussis clinical isolates that differ by pulsed field gel electrophoresis types in the lungs of naïve mice or mice immunized with the whole-cell pertussis vaccine used in Poland. Arch Immunol Ther Exp (Warsz) (2014) 0.75
Mechanism of Vipera berus venom activity and the principles of antivenom administration in treatment. Przegl Epidemiol (2013) 0.75
[Application of DNA microcarriers for evaluation of mice splenocytes genes expression after immunization with pertussis vaccines and challenged with different B. pertussis strains]. Med Dosw Mikrobiol (2007) 0.75
The rate of adverse events following BCG vaccination in Poland. Przegl Epidemiol (2012) 0.75
[Parental attitudes towards childhood immunisations in Poland]. Przegl Epidemiol (2010) 0.75
PCR-based genomic deletion analysis of RD-regions in the identification of mycobacteria isolated from adverse events following BCG vaccination or TB suspected cases. Pol J Microbiol (2014) 0.75
[Increase in the incidence of pertussis and quality of whole-cell pertussis component of the DTP vaccine produced in Poland. Part II. Consistency of control and production]. Przegl Epidemiol (2004) 0.75
[Susceptibility of Lactobacillus rhamnosus strains isolated from probiotic products to antimicrobial agents]. Med Dosw Mikrobiol (2015) 0.75